These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 27538683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.
    Horton MR, Santopietro V, Mathew L, Horton KM, Polito AJ, Liu MC, Danoff SK, Lechtzin N.
    Ann Intern Med; 2012 Sep 18; 157(6):398-406. PubMed ID: 22986377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term safety of nebulized lidocaine for adults with difficult-to-control chronic cough: a case series.
    Lim KG, Rank MA, Hahn PY, Keogh KA, Morgenthaler TI, Olson EJ.
    Chest; 2013 Apr 18; 143(4):1060-1065. PubMed ID: 23238692
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough.
    Louly PG, Medeiros-Souza P, Santos-Neto L.
    Clin Ther; 2009 May 18; 31(5):1007-13. PubMed ID: 19539101
    [Abstract] [Full Text] [Related]

  • 8. Lidocaine inhalation for cough suppression.
    Udezue E.
    Am J Emerg Med; 2001 May 18; 19(3):206-7. PubMed ID: 11326346
    [Abstract] [Full Text] [Related]

  • 9. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, Lapenna D, Giamberardino MA.
    Clin Ther; 2009 Apr 18; 31(4):705-20. PubMed ID: 19446144
    [Abstract] [Full Text] [Related]

  • 10. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.
    Chong CF, Chen CC, Ma HP, Wu YC, Chen YC, Wang TL.
    Emerg Med J; 2005 Jun 18; 22(6):429-32. PubMed ID: 15911951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A, Kumaki C, Niki Y, Suzuki A, Tazawa T, Okamoto H.
    Pain Med; 2009 Jun 18; 10(5):902-9. PubMed ID: 19682274
    [Abstract] [Full Text] [Related]

  • 15. Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability.
    Kamio K, Azuma A, Ohta K, Sugiyama Y, Nukiwa T, Kudoh S, Mizushima T.
    BMC Pulm Med; 2014 May 17; 14():86. PubMed ID: 24886036
    [Abstract] [Full Text] [Related]

  • 16. Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Bischoff JM, Petersen M, Uçeyler N, Sommer C, Kehlet H, Werner MU.
    Anesthesiology; 2013 Dec 17; 119(6):1444-52. PubMed ID: 23887198
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of montelukast in the treatment of cough variant asthma.
    Spector SL, Tan RA.
    Ann Allergy Asthma Immunol; 2004 Sep 17; 93(3):232-6. PubMed ID: 15478381
    [Abstract] [Full Text] [Related]

  • 18. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
    Khalid S, Murdoch R, Newlands A, Smart K, Kelsall A, Holt K, Dockry R, Woodcock A, Smith JA.
    J Allergy Clin Immunol; 2014 Jul 17; 134(1):56-62. PubMed ID: 24666696
    [Abstract] [Full Text] [Related]

  • 19. Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases.
    Aversa C, Cazzola M, Clini V, Dal Negro R, Maiorano V, Tana F, Allegra L.
    Drugs Exp Clin Res; 1993 Jul 17; 19(6):273-9. PubMed ID: 8013271
    [Abstract] [Full Text] [Related]

  • 20. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
    Abdulqawi R, Dockry R, Holt K, Layton G, McCarthy BG, Ford AP, Smith JA.
    Lancet; 2015 Mar 28; 385(9974):1198-205. PubMed ID: 25467586
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.